JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Ziff Davis
ZD
$1.92B
| $12.3M | ﹤0.01% |
163,136
+39,644
| +32% | +$2.74M |
2013 Q2
23 quarters
|
|
|
GAP
1802
PUT
The Gap Inc
GAP
$8.18B
| $12.3M | ﹤0.01% |
+468,500
| New | +$12M |
2019 Q1
0 quarters
|
|
1803
Reinsurance Group of America
RGA
$16.4B
| $12.2M | ﹤0.01% |
86,016
-27,262
| -24% | -$3.92M |
2013 Q2
23 quarters
|
|
1804
Invesco Variable Rate Preferred ETF
VRP
$3B
| $12.2M | ﹤0.01% |
494,761
+214,013
| +76% | +$5.16M |
2016 Q2
11 quarters
|
|
1805
iShares US Home Construction ETF
ITB
$2.31B
| $12.2M | ﹤0.01% |
344,990
+340,157
| +7,038% | +$11.6M |
2013 Q2
23 quarters
|
|
1806
CALL
3M
MMM
$84.2B
| $12.2M | ﹤0.01% |
69,966
+3,110
| +5% | +$524K |
2017 Q3
6 quarters
|
|
1807
CALL
Burlington
BURL
$17.1B
| $12.1M | ﹤0.01% |
+77,500
| New | +$12.5M |
2019 Q1
0 quarters
|
|
|
NUVA
1808
DELISTED
NuVasive, Inc.
NUVA
| $12.1M | ﹤0.01% |
213,457
+27,049
| +15% | +$1.44M |
2013 Q2
23 quarters
|
|
1809
CALL
Best Buy
BBY
$18.3B
| $12.1M | ﹤0.01% |
170,000
+137,500
| +423% | +$8.57M |
2018 Q1
4 quarters
|
|
|
1810
PUT
3M
MMM
$84.2B
| $12.1M | ﹤0.01% |
69,488
-45,806
| -40% | -$7.71M |
2016 Q2
11 quarters
|
|
1811
Crocs
CROX
$5.67B
| $12M | ﹤0.01% |
467,820
+59,801
| +15% | +$1.64M |
2013 Q2
23 quarters
|
|
|
HMHC
1812
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $12M | ﹤0.01% |
1,656,866
-117,520
| -7% | -$1.06M |
2015 Q1
16 quarters
|
|
1813
PUT
Analog Devices
ADI
$203B
| $12M | ﹤0.01% |
114,300
+25,800
| +29% | +$2.59M |
2018 Q2
3 quarters
|
|
|
FOLD
1814
DELISTED
Amicus Therapeutics
FOLD
| $12M | ﹤0.01% |
884,107
-11,973
| -1% | -$146K |
2015 Q3
14 quarters
|
|
|
SWN
1815
DELISTED
Southwestern Energy Company
SWN
| $12M | ﹤0.01% |
2,561,495
+1,108,760
| +76% | +$4.79M |
2013 Q2
23 quarters
|
|
|
SNBR
1816
DELISTED
Sleep Number
SNBR
| $12M | ﹤0.01% |
255,599
-26,137
| -9% | -$1.05M |
2014 Q3
18 quarters
|
|
1817
Ingevity
NGVT
$2.51B
| $12M | ﹤0.01% |
113,737
+64,821
| +133% | +$6.51M |
2016 Q2
11 quarters
|
|
|
ACH
1818
Accendra Health
ACH
$34.7M
| $12M | ﹤0.01% |
2,924,810
-25,584
| -0.9% | -$162K |
2013 Q2
23 quarters
|
|
1819
AngioDynamics
ANGO
$654M
| $12M | ﹤0.01% |
523,715
-21,818
| -4% | -$474K |
2016 Q1
12 quarters
|
|
|
VIAB
1820
DELISTED
Viacom Inc. Class B
VIAB
| $12M | ﹤0.01% |
426,547
-686,457
| -62% | -$19.7M |
2013 Q2
23 quarters
|
|
1821
BGC Group
BGC
$5.8B
| $12M | ﹤0.01% |
2,254,535
-495,975
| -18% | -$2.95M |
2013 Q2
23 quarters
|
|
1822
CALL
Amgen
AMGN
$218B
| $12M | ﹤0.01% |
63,000
-13,300
| -17% | -$2.54M |
2014 Q3
18 quarters
|
|
1823
PUT
CSX Corp
CSX
$87.9B
| $12M | ﹤0.01% |
479,700
+459,900
| +2,323% | +$10.6M |
2016 Q3
10 quarters
|
|
1824
CVR Partners
UAN
$1.33B
| $11.9M | ﹤0.01% |
301,168
+5,826
| +2% | +$222K |
2013 Q4
21 quarters
|
|
|
WBA
1825
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $11.9M | ﹤0.01% |
188,000
+53,400
| +40% | +$3.65M |
2014 Q3
18 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.